Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Amoxicillin	O
/	O
Dilantin	O
Kapseal	O
/	O
adhesive	O
tape	O
/	O
Atenolol	O
/	O
Zestril	O
/	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Lethargy	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
y/o	O
female	O
with	O
a	O
history	O
of	O
multiple	O
drug	O
resistant	O
UTIs	B-Urinary_tract_infection
who	O
presented	O
today	O
with	O
increased	O
lethargy	O
x	O
1	O
day	O
and	O
unusual	O
urine	O
color.	O
Per	O
daughter	O
(who	O
lives	O
with	O
patient),	O
patient	O
slept	O
all	O
day	O
2	O
days	O
PTA	O
and	O
1	O
day	O
PTA	O
was	O
unable	O
to	O
get	O
out	O
of	O
bed,	O
which	O
is	O
unusual	O
for	O
her.	O
Per	O
daughter	O
patient	O
also	O
had	O
unusual	O
"milky	O
white"	O
colored	O
urine	O
starting	O
5	O
days	O
PTA.	O
patient	O
has	O
not	O
had	O
a	O
Foley	O
since	O
this	O
past	O
___	O
but	O
normally	O
uses	O
Depends	O
and	O
is	O
intermittently	O
incontinent.	B-Urinary_incontinence
ROS	O
positive	O
for	O
some	O
urgency	O
and	O
frequency	O
of	O
urination,	O
as	O
well	O
as	O
some	O
loose	O
nonbloody	O
stools	O
starting	O
2	O
days	O
PTA.	O
ROS	O
also	O
positive	O
for	O
some	O
dehydration	O
and	O
decrease	O
PO	O
intake	O
these	O
past	O
few	O
days.	O
ROS	O
negative	O
for	O
fevers,	O
chills,	O
sweats,	O
nausea,	O
vomiting.	O
Of	O
note,	O
Ms.	O
___	O
was	O
recently	O
discharged	O
to	O
rehab	O
on	O
___	O
with	O
a	O
UCx	O
positive	O
for	O
EColi,	O
sensitive	O
to	O
nitrofurantoin	O
x	O
7	O
days.	O
Per	O
daughter	O
patient	O
did	O
not	O
actually	O
receive	O
nitrofurantoin,	O
instead	O
at	O
rehab	O
received	O
some	O
type	O
of	O
IV	O
abx	O
that	O
she	O
does	O
not	O
know	O
the	O
name	O
of.	O
In	O
the	O
ED,	O
vitals	O
were	O
97.5	O
60	O
AV	O
paced	O
139/84	O
20	O
100%	O
RA.	O
UA	O
showed	O
many	O
bacteria,	O
few	O
yeast,	O
182	O
wbc,	O
lg	O
leuk,	O
no	O
nitrite	O
and	O
she	O
was	O
given	O
500	O
NS	O
and	O
transferred	O
to	O
the	O
floor.	O
Past	O
Medical	O
History:	O
#	O
?Recurrent	O
UTI	B-Urinary_tract_infection
--	O
multidrug	O
resistant	O
E	O
Coli	O
#	O
C	O
diff	O
colitis	O
--	O
completed	O
treatment	O
recently	O
#	O
Hypertension	O
#	O
Chronic	O
kidney	O
disease	O
(baseline	O
1.0-1.3)	O
#	O
Pancytopenia	O
--	O
Negative	O
SPEP	O
and	O
UPEP	O
in	O
the	O
past	O
--	O
Felt	O
to	O
be	O
most	O
likely	O
due	O
to	O
myelodysplastic	O
syndrome	O
#	O
PPM	O
--	O
___	O
model	O
___	O
dual-chamber	O
pacemaker	O
--	O
placed	O
in	O
mid	O
___,	O
last	O
generator	O
change	O
in	O
___	O
--	O
last	O
interrogated	O
___	O
and	O
functioning	O
normally	O
#	O
Sick	O
sinus	O
syndrome	O
--	O
Sinus	O
arrest	O
with	O
junctional	O
tachycardia	O
(mid	O
___	O
--	O
required	O
pacemaker	O
placement	O
#	O
Thoracic	O
aortic	O
aneurysm	O
--	O
at	O
level	O
of	O
the	O
diaphragm	O
--	O
CT	O
on	O
___	O
showed	O
aneurysm	O
4	O
cm	O
and	O
unchanged	O
in	O
size	O
#	O
Atrial	O
fibrillation	O
--	O
not	O
anticoagulated	O
due	O
to	O
past	O
subdural	B-Intracranial_haemorrhage
hematoma	B-Intracranial_haemorrhage
#	O
Graves'	O
disease	O
--	O
status	O
post	O
thyroidectomy	O
and	O
radiation	O
#	O
Hypothyroidism	O
#	O
Subdural	B-Intracranial_haemorrhage
hematoma	B-Intracranial_haemorrhage
#	O
Frontal	O
gait	O
syndrome	O
--	O
Diagnosed	O
by	O
Dr.	O
___	O
in	O
___	O
#	O
TIA	O
(___)	O
#	O
Shingles	O
(___)	O
#	O
Osteoarthritis	O
#	O
Falls	B-Falls
#	O
Laryngeal	O
spasm	O
history	O
#	O
Colon	O
polyps	O
status	O
post	O
removal	O
(___)	O
#	O
Hemorrhoids	O
#	O
Urethral	O
polyps	O
s/p	O
cautery	O
Social	O
History:	O
___	O
Family	O
History:	O
#	O
Mother	O
--	O
breast	O
cancer,	O
died	O
of	O
heart	O
disease	O
at	O
age	O
___	O
#	O
Father	O
--	O
died	O
of	O
CAD	O
at	O
age	O
___	O
#	O
Brother	O
--	O
died	O
of	O
appendiceal	O
cancer	O
at	O
age	O
___	O
Physical	O
Exam:	O
Admission:	O
98.2	O
104/63	O
64	O
18	O
99	O
RA	O
Neuro:	O
AOx2	B-Unspecified_cognitive_impairment
(person	O
and	O
date,	O
thinks	O
that	O
hospital	O
is	O
a	O
restaurant).	O
Patient	O
in	O
no	O
accute	O
distress,	O
in	O
good	O
spirits	O
Resp:	O
Good	O
air	O
entry	O
bilaterally,	O
mild	O
bibasilar	O
crackles	O
CV:	O
RRR,	O
___	O
Systolic	O
murmor	O
heard	O
most	O
prominently	O
RUSB.	O
Abd:	O
Abdomen	O
soft,	O
nontender,	O
non-distended.	O
Subcutaneous	O
nodule	O
felt	O
below	O
umbilicus.	O
Foley:	O
Urine	O
milky	O
white	O
in	O
color.	O
Discharge:	O
Refused	O
vitals	O
that	O
AM,	O
but	O
night	O
before:	O
97.6	O
115/68	O
62	O
18	O
100	O
RA	O
Neuro:	O
Refuses	O
to	O
answer	O
questions.	O
When	O
told	O
that	O
her	O
daughter	O
had	O
left	O
her	O
a	O
note,	O
states	O
"I	O
know	O
all	O
about	O
my	O
daughter."	O
"Don't	O
bother	O
me."	O
Resp:	O
Good	O
air	O
entry	O
bilaterally,	O
no	O
crackles	O
appreciated	O
CV:	O
___	O
systolic	O
murmur	O
heard	O
throughout	O
precordium	O
Abd:	O
Grossly	O
nontender,	O
soft,	O
and	O
non	O
distended.	O
Pertinent	O
Results:	O
Admission:	O
___	O
10:10AM	O
BLOOD	O
WBC-5.2	O
RBC-3.61*	O
Hgb-10.5*	O
Hct-32.4*	O
MCV-90	O
MCH-29.0	O
MCHC-32.4	O
RDW-15.6*	O
Plt	O
___	O
___	O
10:10AM	O
BLOOD	O
Neuts-71.5*	O
Lymphs-16.4*	O
Monos-5.8	O
Eos-4.6*	O
Baso-1.7	O
___	O
10:10AM	O
BLOOD	O
Plt	O
___	O
___	O
10:10AM	O
BLOOD	O
Glucose-100	O
UreaN-25*	O
Creat-1.3*	O
Na-138	O
K-4.2	O
Cl-100	O
HCO3-31	O
AnGap-11	O
___	O
10:10AM	O
BLOOD	O
CK(CPK)-159	O
___	O
10:10AM	O
BLOOD	O
CK-MB-2	O
cTropnT-<0.01	O
___	O
10:31AM	O
BLOOD	O
Lactate-2.1*	O
___	O
10:55AM	O
URINE	O
Color-Yellow	O
Appear-Cloudy	O
Sp	O
___	O
___	O
10:55AM	O
URINE	O
Blood-MOD	O
Nitrite-NEG	O
Protein-300	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-6.5	O
Leuks-LG	O
___	O
10:55AM	O
URINE	O
RBC-13*	O
WBC->182*	O
Bacteri-MANY	O
Yeast-NONE	O
Epi-0	O
NonsqEp-0	O
___	O
10:55AM	O
URINE	O
WBC	O
Clm-MANY	O
___	O
10:55AM	O
URINE	O
Discharge:	O
___	O
05:35AM	O
BLOOD	O
WBC-6.3	O
RBC-3.69*	O
Hgb-10.5*	O
Hct-32.8*	O
MCV-89	O
MCH-28.5	O
MCHC-32.0	O
RDW-15.4	O
Plt	O
___	O
___	O
05:35AM	O
BLOOD	O
Plt	O
___	O
___	O
05:35AM	O
BLOOD	O
Glucose-172*	O
UreaN-16	O
Creat-1.0	O
Na-134	O
K-3.9	O
Cl-100	O
HCO3-26	O
AnGap-12	O
Relevant:	O
___	O
05:35AM	O
BLOOD	O
WBC-6.3	O
RBC-3.69*	O
Hgb-10.5*	O
Hct-32.8*	O
MCV-89	O
MCH-28.5	O
MCHC-32.0	O
RDW-15.4	O
Plt	O
___	O
___	O
10:55AM	O
URINE	O
Color-Yellow	O
Appear-Cloudy	O
Sp	O
___	O
___	O
10:55AM	O
URINE	O
Blood-MOD	O
Nitrite-NEG	O
Protein-300	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-6.5	O
Leuks-LG	O
___	O
10:55AM	O
URINE	O
RBC-13*	O
WBC->182*	O
Bacteri-MANY	O
Yeast-NONE	O
Epi-0	O
NonsqEp-0	O
___	O
10:55AM	O
URINE	O
WBC	O
Clm-MANY	O
___	O
10:55	O
am	O
URINE	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
KLEBSIELLA	O
PNEUMONIAE.	O
>100,000	O
ORGANISMS/ML..	O
Cefazolin	O
interpretative	O
criteria	O
are	O
based	O
on	O
a	O
dosage	O
regimen	O
of	O
2g	O
every	O
8h.	O
Piperacillin/Tazobactam	O
Susceptibility	O
testing	O
requested	O
by	O
___	O
___	O
(___)	O
___.	O
Piperacillin/Tazobactam	O
sensitivity	O
testing	O
performed	O
by	O
___	O
___.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
KLEBSIELLA	O
PNEUMONIAE	O
|	O
AMPICILLIN/SULBACTAM--	O
8	O
S	O
CEFAZOLIN-------------	O
<=4	O
S	O
CEFEPIME--------------	O
<=1	O
S	O
CEFTAZIDIME-----------	O
<=1	O
S	O
CEFTRIAXONE-----------	O
<=1	O
S	O
CIPROFLOXACIN---------<=0.25	O
S	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------<=0.25	O
S	O
NITROFURANTOIN--------	O
64	O
I	O
PIPERACILLIN/TAZO-----	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
TRIMETHOPRIM/SULFA----	O
<=1	O
S	O
___	O
9:43	O
pm	O
STOOL	O
CONSISTENCY:	O
NOT	O
APPLICABLE	O
Source:	O
Stool.	O
**FINAL	O
REPORT	O
___	O
C.	O
difficile	O
DNA	O
amplification	O
assay	O
(Final	O
___:	O
Negative	O
for	O
toxigenic	O
C.	O
difficile	O
by	O
the	O
Illumigene	O
DNA	O
amplification	O
assay.	O
(Reference	O
Range-Negative).	O
___	O
10:15	O
am	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine	O
(Preliminary):	O
GRAM	O
POSITIVE	O
COCCUS(COCCI).	O
IN	O
PAIRS	O
AND	O
CLUSTERS.	O
Aerobic	O
Bottle	O
Gram	O
Stain	O
(Final	O
___:	O
Reported	O
to	O
and	O
read	O
back	O
by	O
___	O
___	O
@	O
4:28A	O
___.	O
GRAM	O
POSITIVE	O
COCCI.	O
IN	O
PAIRS	O
AND	O
CLUSTERS.	O
___	O
10:10	O
am	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine	O
(Pending):	O
Brief	O
Hospital	O
Course:	O
#Lethargy:	O
Ms.	O
___	O
is	O
a	O
___	O
y/o	O
female	O
who	O
presented	O
with	O
1	O
day	O
of	O
lethargy	O
most	O
consistent,	O
given	O
her	O
UA	O
results,	O
with	O
a	O
UTI.	B-Urinary_tract_infection
Her	O
UTI	B-Urinary_tract_infection
was	O
initially	O
treated	O
with	O
zosyn	O
and	O
fluconazole	O
(UA	O
initially	O
showed	O
yeast	O
before	O
being	O
corrected	O
by	O
the	O
central	O
laboratory).	O
Her	O
regimen	O
was	O
eventually	O
transitioned	O
to	O
fluconazole	O
(goal	O
total	O
4	O
day	O
course)	O
and	O
ceftriaxone	O
(goal	O
7	O
day	O
course	O
total,	O
including	O
days	O
already	O
administered	O
of	O
zosyn).	O
Her	O
cultures	O
grew	O
Klebisiella	O
sensitive	O
to	O
both	O
zosyn	O
and	O
ceftriaxone.	O
Given	O
her	O
history	O
of	O
recurrent	O
UTIs	B-Urinary_tract_infection
Ms.	O
___	O
received	O
a	O
renal	O
ultrasound	O
that	O
did	O
not	O
show	O
any	O
stone,	O
abscess,	O
or	O
other	O
nitus	O
of	O
infection.	O
Interestingly	O
blood	O
cultures	O
grew	O
___	O
tubes	O
gram	O
positive	O
cocci	O
in	O
pairs	O
and	O
clusters,	O
final	O
speciation	O
pending	O
at	O
time	O
of	O
discharge.	O
It	O
was	O
thought	O
that	O
these	O
cultures	O
represented	O
infection.	O
As	O
part	O
of	O
a	O
full	O
workup	O
CDiff	O
testing	O
was	O
sent	O
which	O
was	O
negative.	O
#Cardiac:	O
Home	O
plavix	O
was	O
continued.	O
While	O
she	O
was	O
in	O
house	O
Ms.	O
___	O
had	O
her	O
regularly	O
scheduled	O
pacemaker	O
interrogation	O
conducted	O
by	O
the	O
inpatient	O
electrophysiology	O
team	O
that	O
showed	O
normal	O
pacing	O
and	O
sensing	O
thresholds.	O
#CKD:	O
Creatinine	O
levels	O
were	O
monitored	O
in	O
house	O
and	O
were	O
normal	O
#Hypothyroidism:	O
Home	O
synthroid	O
was	O
continued.	O
#Transitions	O
of	O
Care:	O
-	O
Please	O
continued	O
fluconazole	O
and	O
ceftriaxone	O
after	O
discharge.	O
Patient	O
requires	O
1	O
more	O
dose	O
of	O
fluconazole	O
and	O
2	O
more	O
days	O
of	O
ceftriaxone.	O
-	O
Please	O
f/u	O
final	O
blood	O
culture	O
results	O
and	O
speciation.	O
Medications	O
on	O
Admission:	O
Preadmission	O
medications	O
listed	O
are	O
correct	O
and	O
complete.	O
Information	O
was	O
obtained	O
from	O
Family/Caregiver.	O
1.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
2.	O
Levothyroxine	O
Sodium	O
75	O
mcg	O
PO	O
4X/WEEK	O
(___)	O
Give	O
before	O
bedtime	O
3.	O
Levothyroxine	O
Sodium	O
50	O
mcg	O
PO	O
3X/WEEK	O
(___)	O
Give	O
before	O
bedtime	O
4.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
5.	O
Calcium	O
Carbonate	O
600	O
mg	O
PO	O
QAM	O
6.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
4X/WEEK	O
(___)	O
Give	O
at	O
lunch	O
Discharge	O
Medications:	O
1.	O
Calcium	O
Carbonate	O
600	O
mg	O
PO	O
QAM	O
2.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
3.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
4X/WEEK	O
(___)	O
Give	O
at	O
lunch	O
4.	O
Levothyroxine	O
Sodium	O
75	O
mcg	O
PO	O
4X/WEEK	O
(___)	O
Give	O
before	O
bedtime	O
5.	O
Levothyroxine	O
Sodium	O
50	O
mcg	O
PO	O
3X/WEEK	O
(___)	O
Give	O
before	O
bedtime	O
6.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
7.	O
Fluconazole	O
100	O
mg	O
IV	O
Q24H	O
Duration:	O
1	O
Days	O
8.	O
CeftriaXONE	O
1	O
gm	O
IV	O
Q24H	O
Duration:	O
2	O
Days	O
9.	O
Miconazole	O
2%	O
Cream	O
1	O
Appl	O
TP	O
BID	O
rash	O
below	O
breasts	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Urinary	B-Urinary_tract_infection
Tract	B-Urinary_tract_infection
Infection	B-Urinary_tract_infection
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Delirium
-	O
always.	O
Level	O
of	O
Consciousness:	O
Lethargic	O
but	O
arousable.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___:	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
for	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
While	O
you	O
were	O
in	O
the	O
hospital	O
we	O
treated	O
your	O
infection	O
with	O
antibiotics	O
and	O
antifungal	O
medications.	O
You	O
are	O
being	O
discharged	O
to	O
a	O
nursing	O
facility	O
for	O
further	O
recovery.	O
Medications	O
Started:	O
Fluconazole	O
(for	O
infection)	O
Ceftriaxone	O
(for	O
infection)	O
Followup	O
Instructions:	O
___	O

